TGen News & Press Releases

Nationwide study of 295,000 brain cancer patients examines differences due to age and sex

Posted Wednesday September 22, 2021

Study by TGen and collaborators documents different outcomes for males and females at various ages

DNA modifications could be used to determine the progression of severe liver disease

Posted Monday September 20, 2021

TGen-led study suggests that modifications of DNA at specific genomic sites correlate with levels of fibrosis in NAFLD and could be used to diagnose the severity of this condition

TGen Joins Nationwide Study of Long COVID-19 Effects in Children and Young Adults

Posted Wednesday September 15, 2021

Mobile labs developed to bring science to the people in an effort to increase participation

Jumpcode Genomics and TGen Partner on Genomic Sequencing of COVID-19

Posted Tuesday September 14, 2021

Collaboration leverages CRISPRclean™ technology for genomic sequencing to help identify and track COVID-19 variants

Socio-economic status of children can influence microorganisms in their digestive tract

Posted Monday September 13, 2021

TGen-led national study suggests how a child’s early environment may influence their health

TGen Names former Dell Executive to Board of Directors

Posted Thursday September 9, 2021

Karen Quintos one of 5 across City of Hope enterprise whose skillsets will be valuable assets to the existing boards of directors, which are filled with accomplished leaders in diverse fields

TGen leads international team to characterize blood-based clues of Parkinson’s Disease

Posted Thursday August 5, 2021

Immune system alterations could provide a path for future diagnostics and studies of this progressively debilitating neurological disease

Helios Scholars at TGen learn teamwork, technique and tenacity

Posted Monday August 2, 2021

Aug. 3 symposium caps 8-week internship of real-life biomedical research sponsored by Helios Education Foundation

TGen looks beyond COVID-19 as it advances pathogen sequencing

Posted Thursday July 15, 2021

Genomic analysis of SARS-CoV-2, aided by seqWell’s technology, increases sequencing output by 10-fold

Like priming a pump, changes in cells damaged by chronic lung disease can result in severe COVID-19

Posted Wednesday July 14, 2021

Results from a TGen-led international study suggest that SARS-CoV-2 takes advantage of genetic changes among patients with pre-existing lung diseases

Prev
[1]
2
3
4
5
Next

Media Contact

Newsletter

News Archive

Latest Posts

Useful Links

Contact Us

Stay up-to-date with TGen